Business Context and Reporting Period
This Form 8-K is a Current Report filed by Sonim Technologies, Inc. (not DNA X, Inc.) on August 13, 2025. The filing addresses a regulatory notice received from The Nasdaq Stock Market LLC regarding the company's compliance with listing standards.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on the status of the company's stock listing and bid price compliance.
Material Changes and Listing Status
- Non-Compliance Notice: Sonim received a notice from Nasdaq stating it failed to meet the minimum bid price requirement of $1.00 per share under Listing Rule 5550(a)(2).
- Deficiency Duration: The deficiency persisted for 30 consecutive business days.
- Current Status: The notice has no immediate effect on the listing; the Common Stock (Symbol: SONM) continues to trade on the Nasdaq Capital Market.
Outlook, Management Commentary, and Risks
- Compliance Period: The company has 180 calendar days (until February 9, 2026) to regain compliance.
- Compliance Criteria: To regain compliance, the closing bid price must be at or above $1.00 per share for a minimum of 10 consecutive business days.
- Remediation Options: Management is evaluating options, including seeking stockholder approval for a reverse stock split at a special meeting or the 2026 annual meeting.
- Second Compliance Period: If the initial period is unsuccessful, Nasdaq may grant a second 180-day period if the company meets other listing standards (e.g., market value of publicly held shares).
- Risks: There is no assurance the company will regain compliance, secure an extension, or avoid delisting. Failure to comply could result in delisting, subject to appeal.
Investor Verification Checklist
- Verify the current closing bid price of SONM to assess proximity to the $1.00 threshold.
- Monitor announcements regarding a special stockholder meeting or the 2026 annual meeting for potential reverse stock split proposals.
- Review the company's most recent Form 10-K and 10-Q for detailed financial health and risk factors not included in this 8-K.
- Track the 180-day compliance timeline ending February 9, 2026.